BICO Group AB (publ) (OTCMKTS:CLLKF – Get Free Report) saw a significant drop in short interest during the month of February. As of February 13th, there was short interest totaling 46 shares, a drop of 96.5% from the January 29th total of 1,313 shares. Based on an average daily volume of 40 shares, the short-interest ratio is presently 1.2 days. Based on an average daily volume of 40 shares, the short-interest ratio is presently 1.2 days.
BICO Group AB (publ) Price Performance
Shares of BICO Group AB (publ) stock remained flat at C$1.79 during trading on Wednesday. The business’s 50-day moving average is C$2.07 and its two-hundred day moving average is C$2.32. BICO Group AB has a 1 year low of C$1.79 and a 1 year high of C$4.21.
About BICO Group AB (publ)
BICO Group AB (publ), formerly known as CELLINK AB, is a biotechnology company specializing in the development and commercialization of tools and solutions for life science research. The company’s core offerings include advanced 3D bioprinters, proprietary bioinks, microfluidic devices and cell analytics instruments. These technologies are designed to accelerate drug discovery, tissue engineering and personalized medicine by enabling researchers to create and analyze complex biological models in vitro.
In addition to its flagship bioprinting platforms, BICO provides a broad portfolio of consumables and software that support end-to-end workflows for cell culture and bioprocessing.
Further Reading
- Five stocks we like better than BICO Group AB (publ)
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for BICO Group AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BICO Group AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
